Live Pharma Import data of Philippines imports from canada under HS Code 30049089000 via Port Ninoy-aquino-int'l-airport , our Philippines customs import data reports include date, value, quantity, product description, HS code, port, country, and Philippines pharma importers data
| Date |
HS Code |
Product Description |
Origin Country |
Custom Name |
QTY. |
Unit |
Weight |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-11-05 00:00:00 |
30049089000
|
PACLITAXEL VIAL 16.7ML (100 MG) LOT: 24S09P/B; EXP 2027/09, 160 VIALS. (FOR CANCER TREATMENT), BIOLYSE PHARMA CORP. | CANADA | Ninoy Aquino Int'l Airport | 6.8 | Kilogram | 865.4 | Importer Name |
2024-11-05 00:00:00
PACLITAXEL VIAL 16.7ML (100 MG) LOT: 24S09P/B; EXP 2027/09, 160 VIALS. (FOR CANCER TREATMENT), BIOLYSE PHARMA CORP.
6.8
Kilogram
865.4
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 30049089000 for Philippines pharma imports from Thailand via Port Ninoy-aquino-int'l-airport.
Port Ninoy-aquino-int'l-airport typically refers to a port that is used for handling and forwarding shipments into Philippines, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharma products, enabling better decision-making for trade and market expansion for Philippines pharma imports from canada under HS code 30049089000 via Port Ninoy-aquino-int'l-airport.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharma market.
